P innovation’s new, generic next-generation dry powder inhaler (DPI) filling technology has become available on the market.

L7 Informatics’ Marcia Blackmoore on how structured data, digital workflows, and real-time orchestration are helping CDMOs deliver at scale without compromising quality.

The U.S. Food and Drug Administration (FDA) has approved Abeona Therapeutics Inc.’s ZEVASKYN gene-modified cellular sheets.

New solutions support high-precision analytics for process development, batch release, and regulatory compliance.

Identiv has entered a strategic business development and marketing partnership with Tag-N-Trac to develop & commercialize ...

RoosterBio Inc. has partnered with Thermo Fisher Scientific to accelerate the availability of new, potentially life-saving ...

Lutris Pharma, a clinical-stage biopharmaceutical company, has appointed Sumant Ramachandra as CEO and a member of its Board ...

Veeva Systems has announced Veeva AI, a new initiative that adds artificial intelligence to the Veeva Vault Platform and ...

Granata Bio has acquired Oviva Therapeutics, a women's health biotech company focused on advancing treatments that address ...

Olon Group, a global pharmaceutical CDMO, appointed Jérôme Bédier as CEO of its French entities and Andrea Conforto as M&S VP ...

Cell and gene therapy manufacturing isn’t just complex—it’s interconnected, dynamic, and constantly evolving. Yet the systems ...

Merck KGaA, Darmstadt, Germany, a science and technology company, has entered into a definitive agreement to acquire ...